QUAN Works to Take Robotics Out of the Lab and Into the Marketplace
The emerging robotics company is exploring new opportunities to shorten the development timeline for some of the world's most astounding robotics advances
May 21, 2012
HOUSTON--Promising new robotics innovations may be poised to improve our lives forever, but many breakthroughs are still years away from commercial availability. Quantum International Corp. (OTCBB:QUAN) is working to change that. The emerging robotics company is exploring new opportunities to shorten the development timeline for some of the world's most astounding robotics advances.
Last week, The Wall Street Journal detailed a new collaboration between researchers at Brown, the Department of Veterans Affairs, Massachusetts General Hospital, Harvard Medical School and the German Aerospace Center that allowed two paralyzed patients to use their thoughts to direct a robotic arm to grasp objects. This incredible advance in the quest to restore some function to people with paralyzed limbs remains years from practical use for people with paralysis or limb loss.
Quantum International aims to help cut the development time between laboratory breakthrough like the one profiled in the Journal to product commercialization. The executive leadership at QUAN has the experience necessary to develop ideas and patents conceived in university labs into new, independent enterprises.
"The technology is already here-we've just got to get it to the marketplace," said QUAN CEO Robert Federowicz. "We're targeting early-stage innovators and research groups with new innovations ready for commercialization and pursuing joint ventures and other deals that would allow us to fund or secure financing for products that could change the face of medicine in the 21st Century.
"This way, Quantum International can deliver powerful robotics innovations to a hungry marketplace while delivering value to our shareholders," he said.
QUAN plans to announce its initial business targets in the red-hot robotics space soon. For more information on Quantum International's robotics initiatives, please visit http://www.quantuminternationalcorp.com/investors.html.
Quantum International Corp. is working to develop the next generation of robotics technology to compete in a booming global industry alongside Hansen Medical, Inc. (NASDAQ: HNSN), MAKO Surgical Corp. (NASDAQ: MAKO), Covidien (NYSE: COV) and Accuray Incorporated (NASDAQ: ARAY).
About QUAN International Corp.
Quantum International Corp. (OTCBB: QUAN) is an emerging robotics innovation company working to commercialize the next generation of sophisticated, automated technology. The Company is positioning itself to develop, deliver and market the most cutting-edge innovations in robotics in order to leverage the worldwide demand for the precision, speed, and cost-effectiveness these technologies offer.
For more information about Quantum International Corp., please visit http://www.quantuminternationalcorp.com.
Featured Product
FAULHABER MICROMO - Impressive accuracy through the latest chip technology
With the launch of the IEP3, FAULHABER expands its product line with an incremental encoder which, thanks to the latest chip technology, achieves a very high resolution and accuracy. With a diameter of just 8 mm, the IEP3 is very lightweight and compact yet still offers a resolution of up to 10,000 lines per revolution - made possible by the latest chip technology with high interpolation. In the standard version, the resolution is freely programmable from 1 - 4,096 lines per revolution. Moreover, the chip technology that is used ensures a high positional accuracy of typically 0.3 °m as well as a high repeatability of typically 0.05 °m thanks to accuracy compensation.
